Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB), a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that data from its Lymphoseek® (technetium Tc 99m tilmanocept) Injection and NAV4694 studies are being presented at the 2013 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) to be held June 8-12, 2013 in Vancouver, Canada.
Help employers find you! Check out all the jobs and post your resume.
